The global smart syringes market is set for robust growth, with an estimated size of USD 1.05 billion in 2024 and a projection to reach USD 2.22 billion by 2033. This represents a ...

WASHINGTON, DC — Two innovations — a syringe that auto-disables so it can't be reused and a blood test that allows extensive results from a tiny sample — are providing low-cost answers to some of the ...

In October 2025, Samsung Bioepis announced that the company will assume full commercial responsibility for BYOOVIZ in Europe upon full transition of Biogen’s commercialization rights back to Samsung ...

DUBLIN, Feb. 12, 2020 /PRNewswire/ -- The "Global Disposable Hypodermic Syringes Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies ...

Fresenius Medical Care (NYSE:FMS) has recalled its Sanxin single-use sterile syringes for reported leakage issues. The syringes are used to draw heparin for hemodialysis. The heparin is then mixed ...

Committee for Medicinal Products for Human Use (CHMP) adopts positive opinion for BYOOVIZ (ranibizumab) pre-filled syringe (PFS) PFS presentation to become ...

CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology ...

CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use ...

Description: The GLO Seal Single-Use Syringe Injector & Dual Adapter kit, SPE-SDSK-CS, contains a 0.3 oz (10 ml) syringe prefilled with GLO Seal, and one dual adapter for injecting into the system.